Concepedia

Inbal Binsky‐Ehrenreich

IB

Statistics

Publications

4

Citations

182

H-Index

4

Active since

2011

Affiliations

Weizmann Institute of Science(Current)

Tel Aviv Sourasky Medical Center

Kaplan Medical Center

Yale University

Inbal Binsky‐Ehrenreich is an author at Weizmann Institute of Science specializing in cell signaling, life sciences, and molecular biology.

Publications per year

2011–2017

4

Publications

4

The Cytokine Midkine and Its Receptor RPTPζ Regulate B Cell Survival in a Pathway Induced by CD74

Sivan Cohen, Or-yam Shoshana, Einat Zelman-Toister et al. · The Journal of Immunology · 2011 · 71 citations · Full text

, , +17

CD84 is a survival receptor for CLL cells

Inbal Binsky‐Ehrenreich, Ayelet Marom, Mirko C. Sobotta et al. · Oncogene · 2013 · 43 citations

, , +6

A phase I‐<scp>II</scp> clinical trial of the anti‐<scp>CD</scp>74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: <i>A patient based approach</i>

Michal Haran, Vita Mirkin, Andrei Braester et al. · British Journal of Haematology · 2017 · 35 citations · Full text

, , +17

CD84 mediates CLL-microenvironment interactions

Ayelet Marom, Avital Barak, Matthias P. Kramer et al. · Oncogene · 2016 · 33 citations

, , +9

1–4 of 4